Inhalation Sciences signs IRS contract worth 1.39 million SEK with new US respiratory pharma client Kumar Jeetendra | September 16, 2022 The current client is a developer of new small molecule treatments for a wide range of respiratory diseases including asthma and COPD. The company has chosen to run dissolution tests on a new substance using ISAB’s leading in vitro lung simulation tool DissolvIt®. DissolvIt® has been increasingly recognized in the inhalation industry as a leading …
Inhalation Sciences receives new IRS orders from returning customers Kumar Jeetendra | May 15, 2025 Inhalation Sciences AB today announces that the company has received two new orders for a total value of EUR 27,400. The orders come from returning customers who have chosen to re-order IRS (Inhalation Research Services) studies via ISAB’s advanced exposure platforms PreciseInhale® and DissolvIt® for ongoing preclinical inhalation studies. In recent weeks, ISAB has received …
